Find a course

Expand

SACT Administration and Patient Care

Credit bearing module

Key facts

Course code

NURS6017

Start dates

January 2022 / September 2022

Application deadline

1 December (for a January start)

1 August (for a September start)

Course length

Part time: Two semesters

Academic level

6

Academic credits

15

This course is not available to students classed as International for fees purposes.

Overview

This is a practice module designed for registered nurses who are required to administer systemic anti-cancer therapy (SACT), or in the case of uro-oncology nurses, intravesical anti-cancer treatment. It will provide you with the opportunity to develop an in-depth understanding of systemic anti-cancer treatments (SACTs). You will develop the required knowledge and skills to be able to autonomously, safely and competently administer systemic or intravesical anti-cancer therapy.

This module has been designed by professionals experienced in delivering a range of cancer care education, as well as being involved in current practice in the administration of systemic or intravesical anti-cancer therapy. The content of this course aligns with National Chemotherapy Measures (NICE 2018) and the UKONS SACT Competency Passport (2019).

September start - mode of delivery, distance learning

January start - mode of delivery, blended learning.

student taking notes

How to apply

Entry requirements

You must be from a respective healthcare background and have support from the clinical manager to undertake this module of study.

You must have an appropriately qualified, nominated practice assessor. Please contact the Module Leader, so that you can discuss the specific practice assessment requirements.

Terms and Conditions of Enrolment

When you accept our offer, you agree to the Terms and Conditions of Enrolment. You should therefore read those conditions before accepting the offer.

Application process

Apply through our Moodle Portal.

You will need to register for the portal prior to proceeding with an application.

Tuition fees

Please see the fees note
2021 / 22
CPD Home (UK) part time
£950

Questions about fees?

Contact Student Finance on:

Tuition fees

2021 / 22
CPD Home (UK) part time
£950

Questions about fees?

Contact Student Finance on:

+44 (0)1865 483088

financefees@brookes.ac.uk

Fees quoted are for the first year only. If you are studying a course that lasts longer than one year your fees will increase each year.

Financial support and scholarships

For general sources of financial support, see our Fees and funding pages.

Additional costs

Please be aware that some courses will involve some additional costs that are not covered by your fees. Specific additional costs for this course, if any, are detailed below.

The published course and module descriptions were accurate when first published and remain the basis of the course, but the University has had to modify some course and module content in response to government restrictions and social distancing requirements. In the event of changes made to the government advice and social distancing rules by national or local government, the University may need to make further alterations to the published course content. Detailed information on the changes will be sent to every student to ensure you have all the information before you come to Oxford Brookes.

Learning and assessment

The teaching, learning and assessment strategy of the module reflects its student centred, patient-centred and practice-focused approach. The module has an appropriate division between structured learning activities and private study. All of the learning methods to be used will engage the student in both academic and practice learning.

You will have to undertake a period of supervised practice in the administration of systemic or intravesical anti-cancer therapy to gain competence in administering systemic or intravesical anti-cancer therapy against learning outcomes. This will be in your own place of work or a practice setting in which systemic or intravesical anti-cancer therapy is given. This will be arranged by your manager, under the supervision of an agreed practice assessor nominated by your manager who meets current national standards, such as the Cancer Measures Chemotherapy Assessor standards.

student doing course work

Learning and teaching

The module explores the biological mechanisms targeted by SACTs, the mechanism of action of SACT, treatment efficacy and side effects of individual drugs. It focuses on the use of stratified healthcare, based on pharmacogenomics data, and the management of treatment-related toxicities in patients receiving SACTS, illustrated by patient case studies.  

The teaching sessions will incorporate the following, delivered over 4 learning units:

  • Cancer biology and rationale for using SACT and intravesical anti-cancer therapy
  • Pharmacology of systemic and intravesical anti-cancer therapy
  • Uses of systemic and anti-cancer therapy
  • Current developments: clinical trials, targeted therapies, personalised medicine
  • Electronic SACT prescriptions and prescription issues
  • Pre-SACT patient assessment
  • The patient experience of SACT.

Assessment

Assessment methods used on this course

100% coursework, assessed by:

  1. Written assignment
  2. UKONS Passport/Workbook
  3. Practice assessment

Programme Changes:

On rare occasions we may need to make changes to our course programmes after they have been published on the website.

For more information, please visit our Changes to programmes page.